Series A - WindMIL Therapeutics
Investment Firm
Overview
WindMIL Therapeutics translates novel insights in bone marrow immunology into life-saving cell therapies for cancer patients.
Announced Date
Apr 07, 2016
Funding Type
Series A
Highlights
Location
United States, North America
Social
Participant Investors
1
| Investor Name |
|---|
Round Details and Background
WindMIL Therapeutics raised $10000000 on 2016-04-07 in Series A
WindMIL Therapeutics translates novel insights in bone marrow immunology into life-saving cell therapies for cancer patients.
Company Funding History
2
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jun 18, 2018 |  Series B - WindMIL Therapeutics | 5 | - | 32.5M |
| Apr 07, 2016 | Series A - WindMIL Therapeutics | 1 | - | 10.0M |
Recent Activity
There is no recent news or activity for this profile.